Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: XKW9MYF94Y

Structure

InChI Key IHIWYQYVBNODSV-KRWDZBQOSA-N
Smile CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1
InChI
InChI=1S/C22H22N4O2/c1-14(2)28-22(27)25-17-10-19-18-9-15(12-23)6-7-20(18)26(21(19)11-17)13-16-5-3-4-8-24-16/h3-9,14,17H,10-11,13H2,1-2H3,(H,25,27)/t17-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H22N4O2
Molecular Weight 374.44
AlogP 3.56
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 79.94
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
MODULATOR Androgen Receptor modulator PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Erectile Dysfunction 2 D007172 ClinicalTrials
Prostatic Hyperplasia 2 D011470 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3542265
DrugBank DB12573
EPA CompTox DTXSID50145591
FDA SRS XKW9MYF94Y
SureChEMBL SCHEMBL2023681
ZINC ZINC000067802526